Lymph node ratio predicts adjuvant chemotherapy benefit in esophageal squamous cell carcinoma
- DOI
- 10.1093/oncolo/oyaf315
- Published
- 2025-09-25
- Container
- The Oncologist
- Publisher
- Oxford University Press (OUP)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1093/oncolo/oyaf315,
title = {Lymph node ratio predicts adjuvant chemotherapy benefit in esophageal squamous cell carcinoma},
author = {Jun Peng and Yi Wang and Haoyue Hu and Lei Wu and Wei Dai and Yehan Zhou and Na Li and Lin Peng and Xuefeng Leng and Xiang Zhuang and Qifeng Wang and Xiang Wang},
year = {2025},
journal = {The Oncologist},
doi = {10.1093/oncolo/oyaf315},
url = {https://doi.org/10.1093/oncolo/oyaf315}
}RIS
TY - JOUR TI - Lymph node ratio predicts adjuvant chemotherapy benefit in esophageal squamous cell carcinoma AU - Jun Peng AU - Yi Wang AU - Haoyue Hu AU - Lei Wu AU - Wei Dai AU - Yehan Zhou AU - Na Li AU - Lin Peng AU - Xuefeng Leng AU - Xiang Zhuang AU - Qifeng Wang AU - Xiang Wang PY - 2025 JO - The Oncologist DO - 10.1093/oncolo/oyaf315 UR - https://doi.org/10.1093/oncolo/oyaf315 ER -
APA
Peng, J., Wang, Y., Hu, H., Wu, L., Dai, W., Zhou, Y., Li, N., Peng, L., Leng, X., Zhuang, X., Wang, Q., & Wang, X. (2025). Lymph node ratio predicts adjuvant chemotherapy benefit in esophageal squamous cell carcinoma. The Oncologist. https://doi.org/10.1093/oncolo/oyaf315
Source records
- crossref · retrieved 2026-09-26T14:48:47.666Z